Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Ross Stores, Inc. (ROST) Price & Performance

BridgeBio Pharma IncTrade
Ross Stores, Inc.Trade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Ross Stores, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.41 (market cap $16.36B), while Ross Stores, Inc. trades at $251.3 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 4.9× BridgeBio Pharma Inc's market cap, and Ross Stores, Inc. pays a 0.71% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

BBIOROST
Market Cap
$16.36B$80.78B
Sector
HealthConsumer Cyclical
52-Week High
$90.17$255.23
52-Week Low
$47.29$144.67
Enterprise Value
$18.14B$81.37B
Dividend Yield
0.71%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Ross Stores, Inc.

Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach

Read more on ROST